Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Liver Diseases

Free Subscription Articles published in Br J Surg Retrieve available abstracts of 82 articles: HTML format

Single Articles

April 2024
1. KRUL MF, Kok NFM, Osmani H, Buisman FE, et al
   Hepatic arterial infusion pump chemotherapy combined with systemic chemotherapy for borderline resectable and unresectable colorectal liver metastases: phase II feasibility study.
   Br J Surg. 2024;111:znae089.
   PubMed     Abstract available
   
   
   
2. AKABANE M, Bekki Y, Imaoka Y, Inaba Y, et al
   Impact of donor characteristics on hepatocellular carcinoma recurrence after liver transplantation.
   Br J Surg. 2024;111:znae080.
   PubMed    
   
   
   
3. JOLIAT GR, de Man R, Rijckborst V, Cimino M, et al
   Long-term outcomes of ruptured hepatocellular carcinoma: international multicentre study.
   Br J Surg. 2024;111:znae093.
   PubMed    
   
   
   March 2024
4. PENG W, Wu Y, Zhang X, Li C, et al
   Liver transplantation for advanced hepatocellular carcinoma after downstaging with consequential lenvatinib, transcatheter arterial chemoembolization and camrelizumab.
   Br J Surg. 2024;111:znae048.
   PubMed    
   
   
   
5. FAN ZQ, Serenari M, Lv X, Schwartz M, et al
   Prognostic significance of nodular number in patients undergoing hepatectomy of intermediate-stage hepatocellular carcinoma.
   Br J Surg. 2024;111:znae047.
   PubMed    
   
   
   
6. MAJLESARA A, Golriz M, Ramouz A, Khajeh E, et al
   Portal vein arterialization as a salvage method in advanced hepatopancreatobiliary surgery.
   Br J Surg. 2024;111:znae053.
   PubMed    
   
   
   
7. MARTIN-CULLELL B, Virgili AC, Riera P, Fumagalli C, et al
   Histopathological, Clinical, And Molecular (HICAM) score for patients with colorectal liver metastases.
   Br J Surg. 2024;111:znae016.
   PubMed     Abstract available
   
   
   January 2024
8. BAUMGARTNER R, Engstrand J, Rajala P, Grip J, et al
   Comparing the accuracy of prediction models to detect clinically relevant post-hepatectomy liver failure early after major hepatectomy.
   Br J Surg. 2024;111:znad433.
   PubMed     Abstract available
   
   
   
9. TZEDAKIS S, Yzhaky Shapira O, Schwarzinger M, Katsahian S, et al
   COVID-19 and excess mortality of patients with liver cancer in France, January 2020-September 2022.
   Br J Surg. 2024;111:znad359.
   PubMed    
   
   
   
10. ENDO Y, Pawlik TM
    Author response to: Comment on: Liver transplantation for elderly patients with early-stage hepatocellular carcinoma.
    Br J Surg. 2024;111:znad423.
    PubMed    
    
    
    
11. MALIK AK, Figueiredo R, White SA
    Comment on: Liver transplantation for elderly patients with early-stage hepatocellular carcinoma.
    Br J Surg. 2024;111:znad426.
    PubMed    
    
    
    November 2023
12. ARNTZ P, Olthof PB
    Assessment of liver function before major hepatectomy.
    Br J Surg. 2023;110:1588-1589.
    PubMed    
    
    
    October 2023
13. 
    Corrigendum to: Variation in treatment of intrahepatic cholangiocarcinoma: a nationwide multicentre study.
    Br J Surg. 2023 Oct 31:znad365. doi: 10.1093.
    PubMed    
    
    
    September 2023
14. PRIMAVESI F, Maglione M, Cipriani F, Denecke T, et al
    E-AHPBA-ESSO-ESSR Innsbruck consensus guidelines for preoperative liver function assessment before hepatectomy.
    Br J Surg. 2023;110:1331-1347.
    PubMed     Abstract available
    
    
    
15. KATAOKA K, Takahashi K, Takeuchi J, Ito K, et al
    Author response to: Comment on: Correlation between recurrence-free survival and overall survival after upfront surgery for resected colorectal liver metastases.
    Br J Surg. 2023;110:1407.
    PubMed    
    
    
    
16. VOIGT KR, Wullaert L, de Graaff MR, Verhoef C, et al
    Association between textbook outcome and long-term survival after surgery for colorectal liver metastases.
    Br J Surg. 2023;110:1284-1287.
    PubMed    
    
    
    August 2023
17. MCCLEMENTS J, Valle JW, Blackburn L, Brooks A, et al
    Variation in treatment of intrahepatic cholangiocarcinoma: a nationwide multicentre study.
    Br J Surg. 2023 Aug 23:znad259. doi: 10.1093.
    PubMed    
    
    
    
18. VAN REES JM, Krul MF, Kok NFM, Grunhagen DJ, et al
    Treatment of locally advanced rectal cancer and synchronous liver metastases: multicentre comparison of two treatment strategies.
    Br J Surg. 2023;110:1049-1052.
    PubMed    
    
    
    
19. ENDO Y, Sasaki K, Moazzam Z, Lima HA, et al
    Liver transplantation for elderly patients with early-stage hepatocellular carcinoma.
    Br J Surg. 2023 Aug 7:znad243. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2023
20. UUTELA A, Nordin A, Osterlund E, Halonen P, et al
    Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study.
    Br J Surg. 2023;110:931-935.
    PubMed    
    
    
    
21. SIRIWARDENA AK, Serrablo A, Fretland AA, Wigmore SJ, et al
    Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE.
    Br J Surg. 2023 Jul 14:znad124. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2023
22. KATAOKA K, Takahashi K, Takeuchi J, Ito K, et al
    Correlation between recurrence-free survival and overall survival after upfront surgery for resected colorectal liver metastases.
    Br J Surg. 2023;110:864-869.
    PubMed     Abstract available
    
    
    
23. MAJLESARA A, Aminizadeh E, Ramouz A, Khajeh E, et al
    Evidence mapping of randomized clinical trials in hepatobiliary surgery.
    Br J Surg. 2023 Jun 1:znad125. doi: 10.1093.
    PubMed    
    
    
    February 2023
24. WENSINK GE, Bolhuis K, Elferink MAG, Fijneman RJA, et al
    Predicting early extrahepatic recurrence after local treatment of colorectal liver metastases.
    Br J Surg. 2023;110:362-371.
    PubMed     Abstract available
    
    
    January 2023
25. PRIMAVESI F, Stattner S, Maglione M
    European guidelines for assessment of liver function before hepatectomy.
    Br J Surg. 2023;110:166-168.
    PubMed    
    
    
    December 2022
26. ZHOU Y
    Comment on: Pathophysiological mechanisms of ALPPS: experimental model.
    Br J Surg. 2022;110:117.
    PubMed    
    
    
    
27. SIJBERDEN JP, Cipriani F, Lanari J, Russolillo N, et al
    Minimally invasive ver-sus open liver resection for hepatocellular carcinoma in the elderly: international multicentre propensity score-matched study.
    Br J Surg. 2022 Dec 13:znac423. doi: 10.1093.
    PubMed    
    
    
    November 2022
28. CHERRIE A
    The end of an era.
    Br J Surg. 2022;109:1181.
    PubMed    
    
    
    
29. WANG XH, Zhou QF, Wang CM, Xiang CL, et al
    Adjuvant transarterial chemoembolization for intermediate-stage hepatocellular carcinoma with microvascular invasion.
    Br J Surg. 2022 Nov 17. pii: 6832194. doi: 10.1093.
    PubMed    
    
    
    October 2022
30. LOPEZ-LOPEZ V, Sanchez-Esquer I, Crespo MJ, Navarro MA, et al
    Development and validation of advanced three-dimensional navigation device integrated in da Vinci Xi(R) surgical robot for hepatobiliary surgery: pilot study.
    Br J Surg. 2022 Oct 26. pii: 6775136. doi: 10.1093.
    PubMed    
    
    
    
31. D'SILVA M, Han HS, Liu R, Kingham TP, et al
    Limited liver resections in the posterosuperior segments: international multicentre propensity score-matched and coarsened exact-matched analysis comparing the laparoscopic and robotic approaches.
    Br J Surg. 2022;109:1140-1149.
    PubMed     Abstract available
    
    
    
32. BUETTNER S, Olthof PB, Wang J, Kreis ME, et al
    Author response to: Comment on: KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations.
    Br J Surg. 2022;109:e122.
    PubMed    
    
    
    
33. LIU QL, Chen HN
    Comment on: KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations.
    Br J Surg. 2022;109:e121.
    PubMed    
    
    
    September 2022
34. PENG W, Zhang X, Li C, Zhu X, et al
    Programmed cell death protein 1 and tyrosine kinase inhibition plus transcatheter arterial chemoembolization of advanced hepatocellular carcinoma.
    Br J Surg. 2022 Sep 27. pii: 6718210. doi: 10.1093.
    PubMed    
    
    
    
35. WONG D, Ng ZQ, Weber D
    Author response to: Comment on: Unfamiliar liver lesions.
    Br J Surg. 2022;109:e115.
    PubMed    
    
    
    
36. DIAO X, Wei L, Zhou H
    Comment on: Unfamiliar liver lesions.
    Br J Surg. 2022;109:e114.
    PubMed    
    
    
    August 2022
37. HOBEIKA C, Cauchy F
    Author response to: Comment on: Performance of non-invasive biomarkers compared with invasive methods for risk prediction of posthepatectomy liver failure in hepatocellular carcinoma.
    Br J Surg. 2022 Aug 18. pii: 6670912. doi: 10.1093.
    PubMed    
    
    
    
38. HUO TI, Ho SY, Liao JI
    Comment on: Performance of non-invasive biomarkers compared with invasive methods for risk prediction of posthepatectomy liver failure in hepatocellular carcinoma.
    Br J Surg. 2022 Aug 18. pii: 6670908. doi: 10.1093.
    PubMed    
    
    
    
39. OLTHOF PB, Buettner S, Andreatos N, Wang J, et al
    KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations.
    Br J Surg. 2022;109:804-807.
    PubMed    
    
    
    July 2022
40. SIJBERDEN JP, Abu Hilal M
    Comment on: Synchronous resection of primary colorectal cancer with liver metastases: two birds with one stone?
    Br J Surg. 2022 Jul 16. pii: 6645296. doi: 10.1093.
    PubMed    
    
    
    
41. PERY R, Smoot RL, Thiels CA, Cleary SP, et al
    Hepatobiliary and pancreatic resection for cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Br J Surg. 2022 Jul 15. pii: 6644759. doi: 10.1093.
    PubMed    
    
    
    June 2022
42. SHEN Q, Li T, Zhou J
    Comment on: Early postoperative arterial lactate concentrations to stratify risk of post-hepatectomy liver failure.
    Br J Surg. 2022;109:e85.
    PubMed    
    
    
    May 2022
43. YOU J, Wu S, Fu Y, Meng L, et al
    Wrapping of the hepatic artery using the round ligament during laparoscopic pancreatoduodenectomy to prevent postpancreatectomy haemorrhage.
    Br J Surg. 2022 May 17. pii: 6586618. doi: 10.1093.
    PubMed    
    
    
    
44. YAQUB S
    Comment on: Synchronous resection of primary colorectal cancer with liver metastases: Two birds with one stone?
    Br J Surg. 2022 May 17. pii: 6587119. doi: 10.1093.
    PubMed    
    
    
    
45. SIRIWARDENA AK
    Author response to: Synchronous resection of primary colorectal cancer with liver metastases: Two birds with one stone?
    Br J Surg. 2022 May 17. pii: 6586615. doi: 10.1093.
    PubMed    
    
    
    
46. WANG R, Quan Z, Zheng T, Wang K, et al
    Pathophysiological mechanisms of ALPPS: experimental model.
    Br J Surg. 2022;109:510-519.
    PubMed     Abstract available
    
    
    
47. SALEH NB, Golse N, Abdallah M, Veziant J, et al
    Preoperative morphometric measurements of liver vasculature to predict postoperative liver failure: bicentric study.
    Br J Surg. 2022;109:554-555.
    PubMed    
    
    
    
48. BJORNELV GMW, Zolic-Karlsson Z, Dueland S, Line PD, et al
    Cost-effectiveness of liver transplantation versus last-resort systemic therapy for colorectal liver metastases.
    Br J Surg. 2022;109:483-485.
    PubMed    
    
    
    
49. WEI F
    Erratum to: Comment on: Laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis.
    Br J Surg. 2022;109:551.
    PubMed    
    
    
    
50. WEI T, Zhang XF, He J, Popescu I, et al
    Prognostic impact of perineural invasion in intrahepatic cholangiocarcinoma: multicentre study.
    Br J Surg. 2022 May 3. pii: 6577149. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2022
51. RAMOUZ A, Ali-Hasan-Al-Saegh S, Shafiei S, Fakour S, et al
    Repeat liver resection for recurrent intrahepatic cholangiocarcinoma: meta-analysis.
    Br J Surg. 2022 Apr 28. pii: 6575275. doi: 10.1093.
    PubMed     Abstract available
    
    
    
52. 
    Unfamiliar liver lesions.
    Br J Surg. 2022;109:432.
    PubMed    
    
    
    
53. VIGANO L, Terrone A, Costa G, Franchi E, et al
    Effect of chemotherapy on tumour-vessel relationship in colorectal liver metastases.
    Br J Surg. 2022;109:401-404.
    PubMed    
    
    
    March 2022
54. YANG HY, Choi GH, Chin KM, Choi SH, et al
    Robotic and laparoscopic right anterior sectionectomy and central hepatectomy: multicentre propensity score-matched analysis.
    Br J Surg. 2022;109:311-314.
    PubMed    
    
    
    February 2022
55. TANAKA S, Iida H, Ueno M, Hirokawa F, et al
    Postoperative loss of independence 1 year after liver resection: prospective multicentre study.
    Br J Surg. 2022;109:e54-e55.
    PubMed    
    
    
    
56. SOREIDE K
    Time to halt perioperative chemotherapy for resectable colorectal liver metastasis?
    Br J Surg. 2022;109:242-243.
    PubMed    
    
    
    
57. HOBEIKA C, Guyard C, Sartoris R, Maino C, et al
    Performance of non-invasive biomarkers compared with invasive methods for risk prediction of posthepatectomy liver failure in hepatocellular carcinoma.
    Br J Surg. 2022 Feb 10. pii: 6525857. doi: 10.1093.
    PubMed     Abstract available
    
    
    
58. CRISTAUDO AT, Morris DL
    Hypothesis to explain the disparity in the proportion of liver metastases between appendiceal and colorectal cancer.
    Br J Surg. 2022 Feb 8. pii: 6524033. doi: 10.1093.
    PubMed    
    
    
    
59. SIRIWARDENA AK
    Synchronous resection of primary colorectal cancer with liver metastases: two birds with one stone?
    Br J Surg. 2022 Feb 3. pii: 6521658. doi: 10.1093.
    PubMed    
    
    
    January 2022
60. WEI F
    Erratum to: Comment on: Laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis.
    Br J Surg. 2022 Jan 5. pii: 6498168. doi: 10.1093.
    PubMed    
    
    
    December 2021
61. HOLMBERG M, Koppatz H, Jansson A, Hillingso JG, et al
    Secondary effects of the COVID-19 pandemic on surgical management of hepatopancreatobiliary malignancies in the Nordic capitals.
    Br J Surg. 2021 Dec 1. pii: 6447105. doi: 10.1093.
    PubMed    
    
    
    
62. DUELAND S, Syversveen T, Hagness M, Grut H, et al
    Liver transplantation for advanced liver-only colorectal metastases.
    Br J Surg. 2021;108:1402-1405.
    PubMed    
    
    
    November 2021
63. SRINIVASAN M, Shaji Mathew J, Mallick S, Nair K, et al
    Middle hepatic vein reconstruction in adult living donor liver transplantation: a randomized clinical trial.
    Br J Surg. 2021 Nov 25. pii: 6439950. doi: 10.1093.
    PubMed     Abstract available
    
    
    
64. NIEDERWIESER T, Braunwarth E, Dasari BVM, Pufal K, et al
    Early postoperative arterial lactate concentrations to stratify risk of post-hepatectomy liver failure.
    Br J Surg. 2021;108:1360-1370.
    PubMed     Abstract available
    
    
    
65. KABIR T, Tan ZZ, Syn NL, Wu E, et al
    Laparoscopic versus open resection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis.
    Br J Surg. 2021 Nov 10. pii: 6424997. doi: 10.1093.
    PubMed     Abstract available
    
    
    
66. WELSCH T, Mussle B, Korn S, Sturm D, et al
    Pancreatoduodenectomy with or without prophylactic falciform ligament wrap around the hepatic artery for prevention of postpancreatectomy haemorrhage: a randomized clinical trial (PANDA trial).
    Br J Surg. 2021 Nov 8. pii: 6422748. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2021
67. ZHOU Q
    Comment on: Laparoscopic and open liver resection for hepatocellular carcinoma with Child-Pugh B cirrhosis: multicentre propensity score-matched study.
    Br J Surg. 2021;108:e350.
    PubMed    
    
    
    
68. ZHONG JH, Xing BC, Zhang WG, Chan AW, et al
    Repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: a retrospective multicentre study.
    Br J Surg. 2021 Oct 13. pii: 6395264. doi: 10.1093.
    PubMed     Abstract available
    
    
    
69. SNEIDERS D, Boteon APCS, Lerut J, Iesari S, et al
    Transarterial chemoembolization of hepatocellular carcinoma before liver transplantation and risk of post-transplant vascular complications: a multicentre observational cohort and propensity score-matched analysis.
    Br J Surg. 2021 Oct 6. pii: 6382003. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2021
70. GORGEC B, Fichtinger RS, Ratti F, Aghayan D, et al
    Comparing practice and outcome of laparoscopic liver resection between high-volume expert centres and nationwide low-to-medium volume centres.
    Br J Surg. 2021;108:983-990.
    PubMed     Abstract available
    
    
    
71. KAWAGUCHI Y, Kopetz S, Tran Cao HS, Panettieri E, et al
    Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status.
    Br J Surg. 2021;108:968-975.
    PubMed     Abstract available
    
    
    
72. MIRANDE MD, Hernandez MC, Nagorney DM
    Corrigendum to: Ingested fishbone causing a hepatic abscess.
    Br J Surg. 2021 Aug 17. pii: 6353225. doi: 10.1093.
    PubMed    
    
    
    
73. RATTI F, Aldrighetti L
    Commentary On "Laparoscopic Versus Open Resection Of Intrahepatic Cholangiocarcinoma: Nationwide Analysis".
    Br J Surg. 2021 Aug 2. pii: 6335751. doi: 10.1093.
    PubMed    
    
    
    July 2021
74. ISONIEMI H, Uutela A, Nordin A, Lantto E, et al
    Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective study.
    Br J Surg. 2021;108:817-825.
    PubMed     Abstract available
    
    
    
75. HOBEIKA C, Cauchy F
    Reply: Commentary on 'laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis'.
    Br J Surg. 2021 Jul 16. pii: 6322942. doi: 10.1093.
    PubMed    
    
    
    June 2021
76. WEI F
    Comment on: Laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis.
    Br J Surg. 2021 Jun 14. pii: 6298428. doi: 10.1093.
    PubMed    
    
    
    May 2021
77. LAYTON GR, Chung WY, Isherwood J, Fraser RE, et al
    Endoscopic retrograde cholangiopancreatography in the COVID era: considerations for hepatobiliary and pancreatic surgery units.
    Br J Surg. 2021 May 17. pii: 6277144. doi: 10.1093.
    PubMed    
    
    
    
78. HOBEIKA C, Cauchy F
    Reply: Can laparoscopic approach improve quality of care of patients with resectable intrahepatic cholangiocarcinoma? (Comment on 'laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis').
    Br J Surg. 2021 May 17. pii: 6277143. doi: 10.1093.
    PubMed    
    
    
    April 2021
79. LIU Y, Chang W, Zhou B, Wei Y, et al
    Conventional transarterial chemoembolization combined with systemic therapy versus systemic therapy alone as second-line treatment for unresectable colorectal liver metastases: randomized clinical trial.
    Br J Surg. 2021;108:373-379.
    PubMed     Abstract available
    
    
    
80. 
    Ingested fishbone causing a hepatic abscess.
    Br J Surg. 2021 Apr 19. pii: 6238564. doi: 10.1093.
    PubMed    
    
    
    
81. 
    Snapshot quiz.
    Br J Surg. 2021;108:270.
    PubMed    
    
    
    March 2021
82. TAKAICHI S, Tomimaru Y, Kobayashi S, Takeda Y, et al
    Drainage after laparoscopic liver surgery in the CSGO-HBP-004 study: propensity score-matched analysis.
    Br J Surg. 2021;108:e57-e58.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.